Top Markets
Coin of the day
Inari Medical, Inc. Inari Medical, Inc.

Inari Medical, Inc.

NARI
株式のランク #3846
Inari Medical, Inc. is a medical technology firm focused on creating,... Inari Medical, Inc. is a medical technology firm focused on creating, producing, promoting, and distributing devices for the minimally invasive management of venous conditions within the United States. Their product portfolio includes ClotTriever, a mechanical thrombectomy solution designed to extract significant clots from major blood vessels, specifically targeting deep vein thrombosis. Another key offering is FlowTriever, a substantial catheter-based aspiration and mechanical thrombectomy system, which addresses pulmonary embolism. The company also provides FlowSaver; FlowStasis, a large-bore suture retention device to manage venous access points; and FlowTriever 2, an enhanced version with a new disk design for efficiently capturing wall-adherent clots and reducing procedure time. Founded in 2011, the company was initially known as Inceptus Newco1 Inc. before rebranding as Inari Medical, Inc. in September 2013. Its corporate headquarters are located in Irvine, California.
株価
$79.97
最終同期: 2025-02-19
時価総額
$4.57B
変化(1日)
0.00%
変化(1年)
0.00%
US
取引 Inari Medical, Inc. (NARI)

カテゴリー

Inari Medical, Inc.(NARI)の収益
Sep 2024 時点の収益 TTM: $574.50M
Inari Medical, Inc. の最新の財務報告によると、現在の収益 (TTM) は $574.50M です。2022 年には $383.47M の収益があり、これは 2021 年の $276.98M と比較して 増加 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
Inari Medical, Inc. の収益履歴(2018 ~ 2026)
各年末の収益
収益 変化
2026 (TTM) $574.50M 16.38%
2023 $493.63M 28.73%
2022 $383.47M 38.45%
2021 $276.98M 98.31%
2020 $139.67M 173.17%
2019 $51.13M 648.70%
2018 $6.83M 0.00%
同業他社の収益
企業 収益 収益の差
$46.59B 8,008.82%
US
$25.84B 4,397.32%
US
$35.48B 6,076.52%
IE
$21.00B 3,554.67%
US
- -
DE